Capital Ideas TV Interview (Posted Feb 4) Highlights:
- CEO Paul Pedersen avoids saying Canopy's name in a negative light, discusses their issues with THC/CBD infusion process then segue's to Nextleafs infusion technology and Bevcanna partnership.
- "We've got an efficient plant that can process about the same amount as the largest processors but we can do it with 20 people instead of 200". Translation: Low prouction/overhead costs.
- White label business still not up and running (awaiting sales license)
- IP licensing and toll processing in revenue.
https://www.youtube.com/watch?v=VQukBWhbGfs&feature=emb_title